Hepatic expression of APOE3 Christchurch mitigates APOE4-related Alzheimer’s disease pathologies in mice
Neuron · 2026
DOI: 10.1016/j.neuron.2026.04.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2026. Verfasst von Jin-Yi Tang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Basic Medical College, Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Chongqing Medica…. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein E3, Apolipoprotein E4, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Municipal Science and Technology Bureau, National Key Research and Development Program of China.
Themen: Demenz
Abstract (Originalsprache)
The ε4 allele of apolipoprotein E (APOE4) is the strongest genetic risk factor for sporadic Alzheimer's disease (AD) and exacerbates AD-related pathologies. Identifying strategies to mitigate the pathogenic effects of APOE4 remains a critical challenge in the field of AD research. The rare APOE3 Christchurch (APOE3Ch) variant has been suggested to be potentially protective against AD. Our study investigated whether hepatic expression of APOE3Ch could mitigate APOE4-associated AD pathologies. We successfully delivered APOE3Ch or APOE3 into the liver by adeno-associated virus in APP/PS1 mice expressing human APOE4. We observed that hepatic APOE3Ch delivery reduced amyloid-β (Aβ) burden in the brain. Hepatic APOE3Ch expression attenuated neuroinflammation, neurodegeneration, and cognitive impairments. Mechanistically, APOE3Ch expression increased the capacity of Aβ clearance by monocytes and hepatocytes. Our findings demonstrate that hepatic APOE3Ch expression attenuates AD-type pathologies in APOE4-expressing APP/PS1 mice, highlighting liver-directed APOE3Ch gene transfer as a promising therapeutic strategy for APOE4-associated AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Basic Medical College, Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Chongqing Medical University, Chongqing 400016, China; Department of Neurology and Cen…
- Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
- Department of Neurobiology, Basic Medical College, Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Chongqing Medical University, Chongqing 400016, China; Department of Psychiatry, the F…
- Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China; Chongqing Key Laboratory of Ageing and Brain Diseases,…
Förderung
- National Natural Science Foundation of China
- Chongqing Municipal Science and Technology Bureau
- National Key Research and Development Program of China
Zitieren
APA
Tang, J. Y., Tan, Q., Yu, Z. Y., Yuan, Z. Y., Zeng, R., Liu, X. Y., Zhu, X. Y., Zhao, Y., Li, J. H., Bai, Y. D., Zeng, G. H., Wang, C., & Wang, Y. J. (2026). Hepatic expression of APOE3 Christchurch mitigates APOE4-related Alzheimer’s disease pathologies in mice. Neuron. https://doi.org/10.1016/j.neuron.2026.04.027
Vancouver
Tang JY, Tan Q, Yu ZY, Yuan ZY, Zeng R, Liu XY, et al. Hepatic expression of APOE3 Christchurch mitigates APOE4-related Alzheimer’s disease pathologies in mice. Neuron. 2026. doi:10.1016/j.neuron.2026.04.027
BibTeX
@article{Tang2026,
author = {Tang, Jin-Yi and Tan, Qi and Yu, Zhong-Yuan and Yuan, Zi-Yu and Zeng, Ru and Liu, Xiao-Yu and Zhu, Xin-Yue and Zhao, Yang and Li, Jiang-Hui and Bai, Yu-Di and Zeng, Gui-Hua and Wang, Chao and Wang, Yan-Jiang},
title = {Hepatic expression of APOE3 Christchurch mitigates APOE4-related Alzheimer’s disease pathologies in mice},
journal = {Neuron},
year = {2026},
doi = {10.1016/j.neuron.2026.04.027}
}
EUVIMED